Cytostatic 6-Arylpurine Nucleosides III. Synthesis and Structure-Activity Relationship Study in Cytostatic Activity of 6-Aryl-, 6-Hetaryl- and 6-Benzylpurine Ribonucleosides

A series of fifteen 6-aryl-, 6-hetaryl- and 6-benzylpurine ribonucleosides has been prepared by Pd-catalyzed cross-coupling reactions of 6-chloro-9-(2,3,5-tri- O -acetyl-β-D-ribofuranosyl)- purine with arylboronic acids, hetarylzinc halides, hetarylstannanes or benzylzinc halides followed by deprotection. Structure-activity relationship study revealed that besides 6-(4-substituted phenyl)purine nucleosides, also some 6-hetaryl- and 6-benzylpurine ribonucleosides possess considerable cytostatic activity.

[1]  J. Montgomery,et al.  Convenient Syntheses of 6-Methylpurine and Related Nucleosides , 2000, Nucleosides, nucleotides & nucleic acids.

[2]  L. Gundersen,et al.  9-Benzylpurines with inhibitory activity against Mycobacterium tuberculosis. , 2000, Bioorganic & medicinal chemistry letters.

[3]  Michal Hocek,et al.  Synthesis and cytostatic activity of substituted 6-phenylpurine bases and nucleosides: application of the Suzuki-Miyaura cross-coupling reactions of 6-chloropurine derivatives with phenylboronic acids. , 2000, Journal of medicinal chemistry.

[4]  Michal Hocek,et al.  Synthesis and cytostatic activity of nucleosides and acyclic nucleoside analogues derived from 6-(trifluoromethyl)purines , 1999 .

[5]  A. Cocuzza,et al.  Use of the Suzuki reaction for the synthesis of aryl-substituted heterocycles as corticotropin-releasing hormone (CRH) antagonists. , 1999, Bioorganic & medicinal chemistry letters.

[6]  G. Gillespie,et al.  Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cells. , 1998, Biochemical pharmacology.

[7]  J. Montgomery,et al.  In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase. , 1997, Human gene therapy.

[8]  Michal Hocek,et al.  Synthesis of acyclic nucleotide analogues derived from N-substituted 6-(1-aminoethyl)purines via 6-acetylpurine derivatives , 1997 .

[9]  L. Gundersen 6-Chloropurines and organostannanes in palladium catalyzed cross coupling reactions , 1994 .

[10]  E. De Clercq,et al.  Antiviral activity of C-alkylated purine nucleosides obtained by cross-coupling with tetraalkyltin reagents. , 1993, Journal of medicinal chemistry.

[11]  H. Nariuchi,et al.  Depletion of mycoplasma from infected cell lines by limiting dilution in 6-methylpurine deoxyriboside. , 1988, Journal of immunological methods.

[12]  D. Carson,et al.  Adenosine phosphorylase-mediated nucleoside toxicity. Application towards the detection of mycoplasmal infection in mammalian cell cultures. , 1982, Experimental cell research.

[13]  Michal Hocek,et al.  Cytostatic 6-Arylpurine Nucleosides II. Synthesis of Sugar-Modified Derivatives: 9-(2-Deoxy-β-D- erythro -pentofuranosyl)-, 9-(5-Deoxy-β-D-ribofuranosyl)- and 9-(2,3-Dihydroxypropyl)-6-phenylpurines , 2000 .

[14]  Michal Hocek,et al.  Synthesis of Acyclic Nucleotide Analogues Derived from 2-Amino-6- C -substituted Purines via Cross-Coupling Reactions of 2-Amino-9-{2-[(diisopropoxyphosphoryl)methoxy]ethyl}-6-halopurines with Diverse Organometallic Reagents , 2000 .

[15]  Michal Hocek,et al.  Perfluoroalkylation of 6-Iodopurines by Trimethyl(perfluoroalkyl)silanes. Synthesis of 6-(Perfluoroalkyl)purine Bases, Nucleosides and Acyclic Nucleotide Analogues , 1999 .

[16]  L. Gundersen,et al.  Synthesis of 6-alkenyl- and 6-alkynylpurines with cytokinin activity , 1999 .

[17]  Michal Hocek,et al.  Synthesis of Acyclic Nucleotide Analogues Derived from 6-Hetarylpurines via Cross-Coupling Reactions of 9-[2-(Diethoxyphosphonylmethoxy)ethyl]-6-iodopurine with Hetaryl Organometallic Reagents , 1997 .

[18]  L. Gundersen,et al.  6-Halopurines in palladium-catalyzed coupling with organotin and organozinc reagents , 1994 .

[19]  C. Reese,et al.  An unambiguous synthesis of adenylosuccinic acid and its constituent nucleoside , 1990 .

[20]  J. Montgomery,et al.  Analogs of 6-methyl-9-beta-D-ribofuranosylpurine. , 1968, Journal of medicinal chemistry.